Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells

Leukemia. 2006 Apr;20(4):729-32. doi: 10.1038/sj.leu.2404114.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD20 / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • Genetic Engineering
  • Humans
  • Immunotherapy / methods*
  • Killer Cells, Natural / immunology*
  • Lymphoma, B-Cell / immunology
  • Lymphoma, B-Cell / therapy*

Substances

  • Antigens, CD20